By using HNSCC xenograft model, we further demonstrated that inhibition of NOTCH1 signaling by γ-secretase inhibitor (GSIs) DAPT is efficacious in downsizing tumor growth and reducing CSCs in HNSCC. The gene discussed is NOTCH1; the disease is head and neck squamous cell carcinoma.